Skip to main content

More Filters

1,092 results

Showing: 501 - 510 of 1092 results
  1. pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (AAV1)

    Viral Prep
    #125712-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (#125712). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE plasmid DNA. CaMKIIa-driven expression of the optimized mosquito OPN3 rhodopsin in-frame with mScarlet. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    short version of αCamKinase II promoter (0.4kb)
    Tags
    mScarlet
    Available Since
    June 26, 2024
    Availability
    Academic Institutions and Nonprofits only
  2. AAV-CAG-jGCaMP8m-WPRE (AAV9)

    Viral Prep
    #179255-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from AAV-CAG-jGCaMP8m-WPRE (#179255). In addition to the viral particles, you will also receive purified AAV-CAG-jGCaMP8m-WPRE plasmid DNA. CAG-driven expression of calcium sensor GCaMP8m. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Available Since
    May 22, 2023
    Availability
    Academic Institutions and Nonprofits only
  3. pAAV-Syn-ChR2(H134R)-GFP (AAV Retrograde)

    Viral Prep
    #58880-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-Syn-ChR2(H134R)-GFP (#58880). In addition to the viral particles, you will also receive purified pAAV-Syn-ChR2(H134R)-GFP plasmid DNA. Humanized channelrhodopsin H134R mutant fused to GFP, under the control of the Synapsin promoter. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    GFP
    Available Since
    June 20, 2017
    Availability
    Academic Institutions and Nonprofits only
  4. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV2)

    Viral Prep
    #87306-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    Aug. 24, 2020
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV_BiCHATe27_dTomato_nlsdTomato (AAV1)

    Viral Prep
    #213829-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiCHATe27_dTomato_nlsdTomato (#213829). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the cholinergic neuron-targeting enhancer E27. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Tags
    dTomato
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
  6. pAAV-hSynapsin1-axon-jGCaMP8m-P2A-mRuby3 (AAV9)

    Viral Prep
    #172922-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hSynapsin1-axon-jGCaMP8m-P2A-mRuby3 (#172922). In addition to the viral particles, you will also receive purified pAAV-hSynapsin1-axon-jGCaMP8m-P2A-mRuby3 plasmid DNA. hSyn-driven expression of jGCaMP8m in axons with cytosolic expression of mRuby3. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available Since
    Aug. 24, 2023
    Availability
    Academic Institutions and Nonprofits only
  7. pAAV-CKIIa-stGtACR2-FusionRed (AAV Retrograde)

    Viral Prep
    #105669-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-CKIIa-stGtACR2-FusionRed (#105669). In addition to the viral particles, you will also receive purified pAAV-CKIIa-stGtACR2-FusionRed plasmid DNA. CaMKIIa-driven, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    FusionRed
    Available Since
    July 8, 2020
    Availability
    Academic Institutions and Nonprofits only
  8. pSMAL-CellTag-V1 (Concentrated Lentiviral Prep)

    Viral Prep
    #115643-LVC
    Purpose
    Ready-to-use Concentrated Lentiviral Prep particles produced from pSMAL-CellTag-V1 (#115643). In addition to the viral particles, you will also receive purified pSMAL-CellTag-V1 plasmid DNA. <p>&lt;p&gt;Ready-to-use lentiviral particles carrying version 1 of the CellTag barcoding library to combinatorially index cells for single-cell analysis of clonal dynamics.&lt;/p&gt;</p>
    Depositor
    Promoter
    Minimal CMV
    Tags
    EGFP
    Available Since
    Oct. 29, 2019
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV-CAG-dLight1.3b (AAV5)

    Viral Prep
    #125560-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-CAG-dLight1.3b (#125560). In addition to the viral particles, you will also receive purified pAAV-CAG-dLight1.3b plasmid DNA. CAG-driven expression of dLight1.3b dopamine sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Available Since
    Oct. 15, 2020
    Availability
    Academic Institutions and Nonprofits only
  10. pENN.AAV.hSyn.Cre.WPRE.hGH (AAV2)

    Viral Prep
    #105553-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pENN.AAV.hSyn.Cre.WPRE.hGH (#105553). In addition to the viral particles, you will also receive purified pENN.AAV.hSyn.Cre.WPRE.hGH plasmid DNA. hSyn-driven Cre expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available Since
    Oct. 21, 2024
    Availability
    Academic Institutions and Nonprofits only
Showing: 501 - 510 of 1092 results